HB-PTSD-001: Safety and Efficacy of HB-1 for PTSD: A Multi-center, Randomized, Double Blind, Placebo-Controlled Study

CONDITION

Mental Health

GENDER

AGE GROUP

From 18

to 65 years

STATUS

Not yet recruiting

Safety and Efficacy of HB-1 for PTSD: A Multi-center, Randomized, Double Blind, Placebo-Controlled Study

Studies Contact Form

  • This field is hidden when viewing the form

Approved By: Bellberry              

Clinical Trial Registry Link: